Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
Clinical trial NCT00326768 · COMPLETED
Trial details
- NCT number
- NCT00326768
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-08-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.